KERRY BALENTINE: Open Payments
NPI 1063518165 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $69 |
| Luye Pharma (USA) Ltd. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: ARISTADA, ERZOFRI EXTENDED-RELEASE, REXULTI, UZEDY, HETLIOZ, COBENFY.
Industry payments across NC — which companies pay providers there.
